Search Results - "Mazurov, A.V."

Legal framework of the functioning of the State regulatory service of ukraine as a subject of the national financial management management by T.A., Kobzeva, A.V., Mazurov

Get full text

Use of Thrombodynamics for revealing the participation of platelet, erythrocyte, endothelial, and monocyte microparticles in coagulation activation and propagation by Lipets, E N, Antonova, O A, Shustova, O N, Losenkova, K V, Mazurov, A V, Ataullakhanov, F I

“…For many pathological states, microparticles are supposed to be one of the causes of hypercoagulation. Although there are some indirect data about…”
Get full text

DNA Aptamers to Thrombin Exosite I. Structure-Function Relationships and Antithrombotic Effects by Spiridonova, V. A., Novikova, T. M., Sizov, V. A., Shashkovskaya, V. S., Titaeva, E. V., Dobrovolsky, A. B., Zharikova, E. B., Mazurov, A. V.

“…DNA aptamers (oligonucleotides) interacting with thrombin exosite I contain G-quadruplex, two T-T, and one T-G-T loops in their structure. They prevent exosite…”
Get full text

Assessment of platelet functional activity in healthy individuals and patients receiving antiplatelet therapy. Possible inconsistencies between aggregation and flow cytometry tests by Bodrova, V V, Shustova, O N, Golubeva, N V, Alieva, A K, Vlodzyanovsky, V V, Pevzner, D V, Mazurov, A V

“…Platelet functional activity was assessed in healthy volunteers (HV, n=92), patients with stable angina pectoris (SA, n=42) and acute coronary syndrome (ACS,…”
Get more information

Activity of tissue factor in microparticles produced in vitro by endothelial cells, monocytes, granulocytes, and platelets by Khaspekova, S. G., Antonova, O. A., Shustova, O. N., Yakushkin, V. V., Golubeva, N. V., Titaeva, E. V., Dobrovolsky, A. B., Mazurov, A. V.

“…Activity of tissue factor (TF) in membrane microparticles (MPs) produced in vitro by endothelial cells (ECs), monocytes, THP-1 monocytic cells, granulocytes,…”
Get full text

Coagulation properties of erythrocyte derived membrane microparticles by Antonova, O A, Shustova, O N, Golubeva, N V, Yakushkin, V V, Alchinova, I B, Karganov, M Y, Mazurov, A V

“…Membrane microparticles (MP) produced upon cell activation and/or damage possess coagulation activity, i.e. ability to accelerate blood clotting. They contain…”
Get more information

Glycoprotein IIb-IIIa content and platelet aggregation in healthy volunteers and patients with acute coronary syndrome by Yakushkin, V.V., Zyuryaev, I.T., Khaspekova, S.G., Sirotkina, O.V., Ruda, M.YA, Mazurov, A.V.

“…Glycoprotein (GP) IIb-IIIa (αIIbβ3-integrin) is the central receptor of platelet aggregation. Activated GP IIb-IIIa binds fibrinogen or von Willebrand factor,…”
Get full text

VARIATIONS OF PLATELET GLYCOPROTEIN IIB-IIIA QUANTITY AFFECTS PLATELET AGGREGATION AND SENSITIVITY TO GLYCOPROTEIN IIB-IIIA ANTAGONISTS by Mazurov, A.V., Khaspekova, S.G., Zabotina, A.M., Shimanova, Y.V., Sirotkina, O.V.

Get full text

Visualization of apo B, fibrinogen/fibrin, and fibronectin in the intima of normal human aorta and large arteries and during atherosclerosis by Shekhonin, B V, Tararak, E M, Samokhin, G P, Mitkevich, O V, Mazurov, A V, Vinogradov, D V, Vlasik, T N, Kalantarov, G F, Koteliansky, V E

“…Apolipoprotein B (apo B), fibrinogen/fibrin, blood platelets, factor VIII-related antigen of the blood coagulation system, and smooth muscle cells (SMC) were…”
Get more information

Characteristics of a New DNA Aptamer, Direct Inhibitor of Thrombin by Mazurov, A. V, Titaeva, E. V, Khaspekova, S. G, Storojilova, A. N, Spiridonova, V. A, Kopylov, A. M, Dobrovolsky, A. B

“…Characteristics of a new antithrombin DNA-aptamer RE31 were studied. This aptamer inhibited thrombin formation in human plasma catalyzed by exogenous…”
Get full text

Mean platelet volume: interactions with platelet aggregation activity and glycoprotein IIb-IIIa and Ib expression levels by Khaspekova, S G, Ziuriaev, I T, Iakushkin, V V, Naĭmushin, Ia A, Sirotkina, O V, Zaĭtseva, N O, Ruda, M Ia, Mazurov, A V

“…Increased mean platelet volume (MPV) is an independent risk factor of thrombotic events in patients with cardiovascular diseases. Interactions of MPV with…”
Get more information

Modification of HCBS at the nanodispersion level by Doroganov, E. A., Mazurov, A. V.

“…The possibility of modifying HCBS by artificial introduction of an optimum amount of nanoparticles in the form of silicic acid gel is studied. It is shown that…”
Get full text

Spontaneous Platelet Aggregation in Patients with Acute Coronary Syndrome by Mazurov, A. V., Khaspekova, S. G., Yakushkin, V. V., Khachikyan, M. V., Zyuryaev, I. T., Ruda, M. Ya

“…Spontaneous platelet aggregation was evaluated in patients with acute coronary syndrome on days 1, 3-5, and 8-12 of the disease. On day 1, aggregation was…”
Get full text

Ability of different glycoprotein IIb-IIIa ligands to support platelet aggregation induced by activating antibody CRC54 by Naimushin, Ya A, Mazurov, A V

“…The ability of different ligands of glycoprotein (GP) IIb-IIIa (alphaIIb/beta3-integrin) to support platelet aggregation stimulated by activating anti-GP…”
Get full text

Monomeric and multimeric blockers of selectins: comparison of in vitro and in vivo activity by Ushakova, N A, Preobrazhenskaya, M E, Bird, M I, Priest, R, Semenov, A V, Mazurov, A V, Nifantiev, N E, Pochechueva, T V, Galanina, O E, Bovin, N V

“…The potency of the oligosaccharides SiaLe(x), SiaLe(a), HSO(3)Le(x), and HSO(3)Le(a), their conjugates with polyacrylamide (PAA, 40 kD), and other monomeric…”
Get full text

Safety, inhibition of platelet aggregation and pharmacokinetics of F(ab′) 2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty by Mazurov, A.V., Pevzner, D.V., Antonova, O.A., Byzova, T.V., Khaspekova, S.G., Semenov, A.V., Vlasik, T.N., Samko, A.N., Staroverov, I.I., Ruda, M.Ya

“…The purpose of the study was to evaluate safety, effects on platelet aggregation and pharmacokinetics of F(ab') 2 fragments of anti-glycoprotein (GP) IIb-IIIa…”
Get full text

Distribution of cell adhesion molecules in cultured endothelial cells from human aorta by Byzova, T.V., Romanov, Y.A., Mazurov, A.V.

Get full text

An extract of feverfew inhibits interactions of human platelets with collagen substrates by Lösche, W, Mazurov, A V, Heptinstall, S, Groenewegen, W A, Repin, V S, Till, U

“…The interaction of platelets with surfaces coated with collagens of type III (C III) or IV (C IV) has been studied by measuring the deposition of 51-Cr-labeled…”
Get more information

Potentiation of platelet interaction with collagen substrates by heparin is insensitive to aspirin by Mazurov, A V, Sinitsyn, V E, Repin, V S

“…The effects of two standard, unfractionated heparin preparations on collagen-induced adhesion and aggregation of platelets were studied by Born aggregometry…”
Get more information

Study of low density lipoprotein interaction with platelets by flow cytofluorimetry by Mazurov, A.V., Preobrazhensky, S.N., Leytin, V.L., Repin, V.S., Smirnov, V.N.

“…Low density lipoproteins (LDL), the main cholesterol carriers in human plasma, affect in vitro platelet aggregation and adhesion. The authors have studied LDL…”
Get full text